OneAscent Financial Services’s Novo Nordisk NVO Stock Holding History

OneAscent Financial Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,319	Closed	-$230K	–	501
2025 Q2	$230K	Sell	3,319 -5,987	-64%	-$407K	0.02%	483
2025 Q1	$644K	Buy	9,306 +4,010	+76%	+$331K	0.04%	285
2024 Q4	$456K	Buy	5,296 +531	+11%	+$57.4K	0.04%	277
2024 Q3	$567K	Buy	+4,765	New	+$635K	0.41%	62
2024 Q2	–	Sell	-3,779	Closed	-$487K	–	332
2024 Q1	$487K	Buy	3,779 +401	+12%	+$47.7K	0.05%	206
2023 Q4	$349K	Sell	3,378 -41	-1%	-$4.05K	0.04%	240
2023 Q3	$311K	Buy	+3,419	New	+$301K	0.08%	180
2022 Q1	–	Sell	-3,696	Closed	-$207K	–	176
2021 Q4	$207K	Buy	+3,696	New	+$200K	0.4%	119
2020 Q4	–	Sell	-6,556	Closed	-$228K	–	165
2020 Q3	$228K	Buy	+6,556	New	+$219K	0.12%	162

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OneAscent Financial Services's NVO Position: Q3 2025 in Review

OneAscent Financial Services sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,319 shares — an estimated $230K sold.

OneAscent Financial Services first reported a position in NVO in Q3 2020 and held it in 9 quarters. The position peaked at $644K in Q1 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

OneAscent Financial Services reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
OneAscent Financial Services sold 3,319 Novo Nordisk shares in Q3 2025, an estimated $230K.
OneAscent Financial Services first reported a position in Novo Nordisk in Q3 2020 and held it in 9 quarters.
OneAscent Financial Services's Novo Nordisk position peaked at $644K in Q1 2025.
1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on OneAscent Financial Services's 13F filing for Q3 2025, filed 22 Oct 2025.